An advisory panel voted in June to recommend loosening restrictions put in place in 2010, when the FDA limited Avandia use to patients with type 2 diabetes who could not control their illness with other medications.
eHealthcare Solutions (EHS) manages advertising on this website.
We use cookies to ensure that we give you the best experience on our website.
By continuing, you agree to the use of cookies as per the EHS Privacy Policy